These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 15103321

  • 1. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin.
    Kushibiki T, Matsumoto K, Nakamura T, Tabata Y.
    Gene Ther; 2004 Aug; 11(15):1205-14. PubMed ID: 15103321
    [Abstract] [Full Text] [Related]

  • 2. Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres.
    Kushibiki T, Matsumoto K, Nakamura T, Tabata Y.
    Pharm Res; 2004 Jul; 21(7):1109-18. PubMed ID: 15290849
    [Abstract] [Full Text] [Related]

  • 3. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T.
    Cancer Res; 2000 Dec 01; 60(23):6737-43. PubMed ID: 11118060
    [Abstract] [Full Text] [Related]

  • 4. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4.
    Saimura M, Nagai E, Mizumoto K, Maehara N, Minamishima YA, Katano M, Matsumoto K, Nakamura T, Tanaka M.
    Clin Cancer Res; 2002 Oct 01; 8(10):3243-9. PubMed ID: 12374695
    [Abstract] [Full Text] [Related]

  • 5. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice.
    Wen J, Matsumoto K, Taniura N, Tomioka D, Nakamura T.
    Cancer Gene Ther; 2004 Jun 01; 11(6):419-30. PubMed ID: 15017381
    [Abstract] [Full Text] [Related]

  • 6. Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice.
    Son G, Hirano T, Seki E, Iimuro Y, Nukiwa T, Matsumoto K, Nakamura T, Fujimoto J.
    J Hepatol; 2006 Nov 01; 45(5):688-95. PubMed ID: 16839638
    [Abstract] [Full Text] [Related]

  • 7. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.
    Saimura M, Nagai E, Mizumoto K, Maehara N, Okino H, Katano M, Matsumoto K, Nakamura T, Narumi K, Nukiwa T, Tanaka M.
    Cancer Gene Ther; 2002 Oct 01; 9(10):799-806. PubMed ID: 12224019
    [Abstract] [Full Text] [Related]

  • 8. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
    Heideman DA, van Beusechem VW, Bloemena E, Snijders PJ, Craanen ME, Offerhaus GJ, Derksen PW, de Bruin M, Witlox MA, Molenaar B, Meijer CJ, Gerritsen WR.
    J Gene Med; 2004 Mar 01; 6(3):317-27. PubMed ID: 15026993
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of colon cancer growth and metastasis by NK4 gene repetitive delivery in mice.
    Wen J, Matsumoto K, Taniura N, Tomioka D, Nakamura T.
    Biochem Biophys Res Commun; 2007 Jun 22; 358(1):117-23. PubMed ID: 17467663
    [Abstract] [Full Text] [Related]

  • 10. Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA-PEG engrafted cationized dextran complex and ultrasound irradiation.
    Hosseinkhani H, Kushibiki T, Matsumoto K, Nakamura T, Tabata Y.
    Cancer Gene Ther; 2006 May 22; 13(5):479-89. PubMed ID: 16276347
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
    Tomioka D, Maehara N, Kuba K, Mizumoto K, Tanaka M, Matsumoto K, Nakamura T.
    Cancer Res; 2001 Oct 15; 61(20):7518-24. PubMed ID: 11606388
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Growth suppression of subcutaneous tumor by CT26 expressing NK4 in syngeneic mice].
    Kubota T, Fujiwara H, Amaike H, Takashima K, Inada S, Atsuji K, Yoshimura M, Matsumoto K, Nakamura T, Yamagishi H.
    Gan To Kagaku Ryoho; 2002 Nov 15; 29(12):2258-60. PubMed ID: 12484049
    [Abstract] [Full Text] [Related]

  • 16. Tumor suppression effect using NK4, a molecule acting as an antagonist of HGF, on human gastric carcinomas.
    Hirao S, Yamada Y, Koyama F, Fujimoto H, Takahama Y, Ueno M, Kamada K, Mizuno T, Maemondo M, Nukiwa T, Matsumoto K, Nakamura T, Nakajima Y.
    Cancer Gene Ther; 2002 Aug 15; 9(8):700-7. PubMed ID: 12136432
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of NK4 gene transfection on tumor growth of human pancreatic cancer xenograft in nude mice].
    Lai RX, Zhang SN, Nakamura T, Yuan SZ.
    Ai Zheng; 2005 Oct 15; 24(10):1191-5. PubMed ID: 16219131
    [Abstract] [Full Text] [Related]

  • 19. Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy.
    Maemondo M, Narumi K, Saijo Y, Usui K, Tahara M, Tazawa R, Hagiwara K, Matsumoto K, Nakamura T, Nukiwa T.
    Mol Ther; 2002 Feb 15; 5(2):177-85. PubMed ID: 11829525
    [Abstract] [Full Text] [Related]

  • 20. Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model.
    Tanaka T, Shimura H, Sasaki T, Narumi K, Maemondo M, Nukiwa T, Matsumoto K, Nakamura T, Ikeda S.
    Cancer Gene Ther; 2004 Jun 15; 11(6):431-40. PubMed ID: 15118756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.